市場調査レポート

商品コード

1625252

バイオフォトニクス市場の2030年までの予測：技術別、用途別、エンドユーザー別、地域別の世界分析

Biophotonics Market Forecasts to 2030 - Global Analysis By Technology (In-vivo and In-vitro), Application, End User and By Geography

出版日: 2025年01月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 595,815円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 753,742円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 911,669円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,076,775円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、バイオフォトニクスの世界市場は2024年に760億8,000万米ドルを占め、予測期間中にCAGR 12.2％で成長し、2030年には1,517億9,000万米ドルに達する見込みです。

バイオフォトニクスは、生物学と医学における光ベースの技術の研究と応用です。細胞、組織、臓器などの生体システムを理解し操作するために光を利用します。この学際的な分野は、物理学、生物学、工学の原理を組み合わせ、イメージング、診断、治療、治療のためのツールを開発します。蛍光顕微鏡、光コヒーレンストモグラフィ、レーザーを用いた治療などの技術はバイオフォトニクスでは一般的であり、医療用イメージング、疾患検出、標的治療などの分野における進歩を可能にしています。

政府支援と資金調達

政府機関からの資金援助は、しばしば新しいバイオフォトニクス技術の開発を加速させ、医療診断、イメージング、治療における画期的な進歩を可能にします。助成金、補助金、税制上の優遇措置は、民間会社のバイオフォトニクスへの投資を促し、新規技術の開発に伴う財務リスクを軽減します。さらに、公的資金は大学、研究機関、業界リーダー間の協力を支援し、バイオフォトニクス製品の商業化を促進しています。ヘルスケアと医療機器の発展を目指す政府のイニシアチブは、臨床や研究室でのバイオフォトニックアプリケーションの需要をさらに促進します。このような総合的な支援は、市場の成長を促すだけでなく、最先端技術の主流ヘルスケアソリューションへの統合を確実なものにしています。

技術的限界

フォトニクスと生体システムとの融合は複雑であり、精度と信頼性に課題があります。先進的なバイオフォトニクス技術に関連する高コストが、研究や臨床アプリケーションへの普及を制限しています。機器間の標準化と相互運用性の欠如は、既存のヘルスケアインフラへのシームレスな統合を妨げています。さらに、イメージングシステムの感度と解像度に限界があるため、正確な診断や治療モニタリングができないです。最後に、バイオフォトニクスツールの操作には専門的な訓練と専門知識が必要であることも、普及を阻む要因となっています。

再生医療への応用拡大

レーザーベースの治療やイメージング技術など、組織再生における光ベースの技術の使用は、治療の精度と有効性を高めています。バイオフォトニクスは、細胞プロセスのより良い可視化とモニタリングを可能にし、これは新しい再生療法の開発において極めて重要です。幹細胞研究や遺伝子治療の進歩に伴い、バイオフォトニクスツールは細胞挙動や組織再生の追跡に不可欠です。非侵襲的な診断ツールに対する需要も、再生医療におけるバイオフォトニクスの成長に寄与しています。再生医療が進化し続ける中、バイオフォトニクスは画期的な治療を可能にし、患者の転帰を改善する上で重要な役割を果たしています。

プライバシーとデータセキュリティへの懸念

バイオフォトニクスアプリケーションを通じて生成される医療データは機密性が高いため、不正アクセスや悪用が懸念されます。GDPRなどの厳しい規制により、バイオフォトニクス企業は安全なシステムに多額の投資を行う必要があり、運用コストがかさみます。データ保護対策が不十分な場合、情報漏えいの可能性があり、企業の評判や信用が損なわれます。個人健康情報の共有に消極的な消費者は、バイオフォトニクス技術の採用をさらに遅らせる。その結果、こうした懸念が医療診断や治療における革新的なバイオフォトニクスソリューションの普及を遅らせています。

COVID-19の影響

COVID-19の大流行は、製造、サプライチェーン、研究活動に混乱をもたらし、バイオフォトニクス市場に大きな影響を与えました。しかし、ヘルスケア、特に診断・治療用途でのバイオフォトニクスの採用も加速しました。COVID-19の検出やモニタリングなど、迅速で非侵襲的な検査に対する需要の高まりが、光学バイオセンサーやイメージングシステムの技術革新を推進しました。初期の挫折にもかかわらず、パンデミックは医療診断におけるバイオフォトニクスの重要性を浮き彫りにし、ヘルスケア技術への投資が世界的に増加するにつれて、この分野の長期的な成長見通しを押し上げました。

予測期間中、生体内セグメントが最大になる見込み

生体内セグメントは、生物学的プロセスのリアルタイムイメージングとモニタリングを可能にすることで、有利な成長が見込まれます。組織、細胞、臓器を非侵襲的に高解像度で可視化できるため、診断精度や治療モニタリングが向上します。個別化医療や病気の早期発見に対する需要の高まりが、生体内バイオフォトニクスの採用をさらに後押ししています。さらに、創薬や前臨床試験への応用により、医薬品開発の効率と成功率が向上し、市場開拓の原動力となっています。研究投資の増加とヘルスケアの進歩により、生体内セグメントはバイオフォトニクス市場の将来を形成し続けています。

医療治療セグメントは予測期間中に最も高いCAGRが見込まれる

医療治療セグメントは、高度な診断・治療法により、予測期間中に最も高いCAGR成長が見込まれます。バイオフォトニクスは、光コヒーレンストモグラフィ（OCT）のような非侵襲的イメージング技術を容易にし、病気の検出とモニタリングを強化します。また、バイオフォトニクスは標的治療をサポートし、がんなどの治療精度を向上させる。さらに、レーザー技術の革新は、より効果的な手術と回復時間の短縮を可能にします。ヘルスケアの要求が進化するにつれ、患者ケアの改善における医療分野のバイオフォトニクスへの依存は拡大し続け、市場成長を刺激しています。

最大シェアの地域

アジア太平洋地域は、ヘルスケア、農業、環境分野の進歩により、予測期間中最大の市場シェアを占めると予想されます。慢性疾患の有病率の上昇と相まって、画像診断や分光法などの診断技術に対する需要の高まりが市場を後押ししています。この地域のバイオテクノロジーと医療機器産業は、バイオフォトニクスの需要にさらに貢献しています。中国、日本、インドなどの国々は、研究開発に多額の投資を行い、治療・診断アプリケーションのイノベーションを促進しています。

CAGRが最も高い地域：

北米は、医療診断、治療、研究アプリケーションの進歩により、予測期間中最も高いCAGRが見込まれています。主要技術には、光コヒーレンストモグラフィ（OCT）、蛍光イメージング、ラマン分光法などがあり、がん検出、ドラッグデリバリー、組織分析などに広く利用されています。この地域は、強固なヘルスケアインフラ、研究開発への多額の投資、非侵襲的診断技術への高い需要などの恩恵を受けています。米国とカナダの大手企業は革新的なソリューションに投資し、成長を促進しています。ヘルスケアに対する意識の高まりと相まって、政府のイニシアチブは北米市場の拡大をさらに後押ししています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場企業の包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第9章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品発売
事業拡大
その他の主要戦略

第10章企業プロファイリング

Thermo Fisher Scientific Inc.
Carl Zeiss AG
Horiba Ltd.
Olympus Corporation
Abcam Plc
Biolitec AG
Agilent Technologies Inc.
Sartorius AG
Lumenis Ltd.
PerkinElmer Inc.
LightLab Imaging, Inc.
Medtronic Plc
Photonis Technologies
Nikon Corporation
Beckman Coulter, Inc.

図表

List of Tables

Table 1 Global Biophotonics Market Outlook, By Region (2022-2030) ($MN)
Table 2 Global Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
Table 3 Global Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
Table 4 Global Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
Table 5 Global Biophotonics Market Outlook, By Application (2022-2030) ($MN)
Table 6 Global Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
Table 7 Global Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
Table 8 Global Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
Table 9 Global Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
Table 10 Global Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
Table 11 Global Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
Table 12 Global Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
Table 13 Global Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
Table 14 Global Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
Table 15 Global Biophotonics Market Outlook, By End User (2022-2030) ($MN)
Table 16 Global Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
Table 17 Global Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
Table 18 Global Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
Table 19 Global Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
Table 20 Global Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
Table 21 North America Biophotonics Market Outlook, By Country (2022-2030) ($MN)
Table 22 North America Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
Table 23 North America Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
Table 24 North America Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
Table 25 North America Biophotonics Market Outlook, By Application (2022-2030) ($MN)
Table 26 North America Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
Table 27 North America Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
Table 28 North America Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
Table 29 North America Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
Table 30 North America Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
Table 31 North America Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
Table 32 North America Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
Table 33 North America Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
Table 34 North America Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
Table 35 North America Biophotonics Market Outlook, By End User (2022-2030) ($MN)
Table 36 North America Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
Table 37 North America Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
Table 38 North America Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
Table 39 North America Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
Table 40 North America Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
Table 41 Europe Biophotonics Market Outlook, By Country (2022-2030) ($MN)
Table 42 Europe Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
Table 43 Europe Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
Table 44 Europe Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
Table 45 Europe Biophotonics Market Outlook, By Application (2022-2030) ($MN)
Table 46 Europe Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
Table 47 Europe Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
Table 48 Europe Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
Table 49 Europe Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
Table 50 Europe Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
Table 51 Europe Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
Table 52 Europe Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
Table 53 Europe Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
Table 54 Europe Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
Table 55 Europe Biophotonics Market Outlook, By End User (2022-2030) ($MN)
Table 56 Europe Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
Table 57 Europe Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
Table 58 Europe Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
Table 59 Europe Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
Table 60 Europe Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
Table 61 Asia Pacific Biophotonics Market Outlook, By Country (2022-2030) ($MN)
Table 62 Asia Pacific Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
Table 63 Asia Pacific Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
Table 64 Asia Pacific Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
Table 65 Asia Pacific Biophotonics Market Outlook, By Application (2022-2030) ($MN)
Table 66 Asia Pacific Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
Table 67 Asia Pacific Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
Table 68 Asia Pacific Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
Table 69 Asia Pacific Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
Table 70 Asia Pacific Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
Table 71 Asia Pacific Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
Table 72 Asia Pacific Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
Table 73 Asia Pacific Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
Table 74 Asia Pacific Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
Table 75 Asia Pacific Biophotonics Market Outlook, By End User (2022-2030) ($MN)
Table 76 Asia Pacific Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
Table 77 Asia Pacific Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
Table 78 Asia Pacific Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
Table 79 Asia Pacific Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
Table 80 Asia Pacific Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
Table 81 South America Biophotonics Market Outlook, By Country (2022-2030) ($MN)
Table 82 South America Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
Table 83 South America Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
Table 84 South America Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
Table 85 South America Biophotonics Market Outlook, By Application (2022-2030) ($MN)
Table 86 South America Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
Table 87 South America Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
Table 88 South America Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
Table 89 South America Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
Table 90 South America Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
Table 91 South America Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
Table 92 South America Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
Table 93 South America Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
Table 94 South America Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
Table 95 South America Biophotonics Market Outlook, By End User (2022-2030) ($MN)
Table 96 South America Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
Table 97 South America Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
Table 98 South America Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
Table 99 South America Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
Table 100 South America Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
Table 101 Middle East & Africa Biophotonics Market Outlook, By Country (2022-2030) ($MN)
Table 102 Middle East & Africa Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
Table 103 Middle East & Africa Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
Table 104 Middle East & Africa Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
Table 105 Middle East & Africa Biophotonics Market Outlook, By Application (2022-2030) ($MN)
Table 106 Middle East & Africa Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
Table 107 Middle East & Africa Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
Table 108 Middle East & Africa Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
Table 109 Middle East & Africa Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
Table 110 Middle East & Africa Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
Table 111 Middle East & Africa Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
Table 112 Middle East & Africa Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
Table 113 Middle East & Africa Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
Table 114 Middle East & Africa Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
Table 115 Middle East & Africa Biophotonics Market Outlook, By End User (2022-2030) ($MN)
Table 116 Middle East & Africa Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
Table 117 Middle East & Africa Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
Table 118 Middle East & Africa Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
Table 119 Middle East & Africa Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
Table 120 Middle East & Africa Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)

Product Code: SMRC28207

According to Stratistics MRC, the Global Biophotonics Market is accounted for $76.08 billion in 2024 and is expected to reach $151.79 billion by 2030 growing at a CAGR of 12.2% during the forecast period. Biophotonics is the study and application of light-based technologies in biological and medical sciences. It involves using light to understand and manipulate biological systems, such as cells, tissues, and organs. This interdisciplinary field combines principles from physics, biology, and engineering to develop tools for imaging, diagnosis, therapy, and treatment. Techniques like fluorescence microscopy, optical coherence tomography, and laser-based therapies are common in biophotonics, enabling advancements in areas such as medical imaging, disease detection, and targeted treatments.

Market Dynamics:

Driver:

Government support and funding

Financial backing from government agencies often accelerates the development of new biophotonic technologies, enabling breakthroughs in medical diagnostics, imaging, and therapy. Grants, subsidies, and tax incentives encourage private companies to invest in biophotonics, reducing the financial risks associated with developing novel technologies. Additionally, public funding supports collaborations between universities, research institutions, and industry leaders, facilitating the commercialization of biophotonic products. Government initiatives aimed at advancing healthcare and medical devices further drive demand for biophotonic applications in clinical and laboratory settings. This collective support not only stimulates market growth but also ensures the integration of cutting-edge technologies into mainstream healthcare solutions.

Restraint:

Technical limitations

Complexities in integrating photonics with biological systems create challenges in precision and reliability. High costs associated with advanced biophotonics technologies restrict their widespread adoption in research and clinical applications. The lack of standardization and interoperability between devices hampers seamless integration into existing healthcare infrastructures. Additionally, limitations in the sensitivity and resolution of imaging systems prevent accurate diagnostics and therapeutic monitoring. Finally, the need for specialized training and expertise to operate biophotonics tools adds another barrier to widespread implementation.

Opportunity:

Expanding applications in regenerative medicine

The use of light-based technologies in tissue regeneration, such as laser-based therapies and imaging techniques, is enhancing the precision and effectiveness of medical treatments. Biophotonics enables better visualization and monitoring of cellular processes, which is critical in developing new regenerative therapies. With advances in stem cell research and gene therapy, biophotonics tools are essential for tracking cellular behavior and tissue regeneration. The demand for non-invasive diagnostic tools also contributes to the growth of biophotonics in regenerative medicine. As regenerative medicine continues to evolve, biophotonics plays a crucial role in enabling groundbreaking therapies and improving patient outcomes.

Threat:

Privacy and data security concerns

The sensitive nature of medical data generated through biophotonics applications raises fears of unauthorized access and misuse. Stringent regulations, such as GDPR, require biophotonics companies to invest heavily in secure systems, adding to operational costs. Inadequate data protection measures can lead to potential breaches, harming a company's reputation and credibility. Consumer reluctance to share personal health information further slows adoption of biophotonics technologies. Consequently, these concerns delay the widespread implementation of innovative biophotonics solutions in medical diagnostics and treatment.

Covid-19 Impact

The Covid-19 pandemic significantly impacted the biophotonics market, with disruptions in manufacturing, supply chains, and research activities. However, it also accelerated the adoption of biophotonics in healthcare, particularly for diagnostic and therapeutic applications. Increased demand for rapid, non-invasive testing, such as for Covid-19 detection and monitoring, drove innovations in optical biosensors and imaging systems. Despite initial setbacks, the pandemic highlighted the importance of biophotonics in medical diagnostics, boosting long-term growth prospects in the sector as investment in healthcare technologies increased globally.

The in-vivo segment is expected to be the largest during the forecast period

The in-vivo segment is estimated to have a lucrative growth, by enabling real-time imaging and monitoring of biological processes. It allows for non-invasive, high-resolution visualization of tissues, cells, and organs, enhancing diagnostic accuracy and treatment monitoring. The growing demand for personalized medicine and early disease detection further fuels the adoption of in-vivo biophotonics. Additionally, its applications in drug discovery and pre-clinical studies drive market growth by improving the efficiency and success rates of pharmaceutical developments. With increasing research investments and healthcare advancements, the in-vivo segment continues to shape the future of the Biophotonics market.

The medical therapeutic segment is expected to have the highest CAGR during the forecast period

The medical therapeutic segment is anticipated to witness the highest CAGR growth during the forecast period, due to advanced diagnostic and treatment methods. It facilitates non-invasive imaging techniques, such as optical coherence tomography (OCT), which enhances disease detection and monitoring. Biophotonics also supports targeted therapies, improving the precision of treatments for conditions like cancer. Additionally, innovations in laser technologies allow for more effective surgeries with faster recovery times. As healthcare demands evolve, the medical sector's reliance on biophotonics for improved patient care continues to expand, stimulating market growth.

Region with largest share:

Asia Pacific is expected to hold the largest market share during the forecast period by advancements in healthcare, agriculture, and environmental sectors. Increasing demand for diagnostic technologies, such as imaging and spectroscopy, coupled with the rising prevalence of chronic diseases, is propelling the market. The region's booming biotechnology and medical device industries further contribute to the demand for biophotonics. Countries like China, Japan, and India are at the forefront, with substantial investments in research and development, fostering innovation in therapeutic and diagnostic applications.

Region with highest CAGR:

North America is expected to have the highest CAGR over the forecast period, owing to advancements in medical diagnostics, therapeutics, and research applications. Key technologies include optical coherence tomography (OCT), fluorescence imaging, and Raman spectroscopy, widely used in cancer detection, drug delivery, and tissue analysis. The region benefits from a robust healthcare infrastructure, substantial investments in research and development, and a high demand for non-invasive diagnostic techniques. Leading players in the U.S. and Canada are investing in innovative solutions, fostering growth. Government initiatives, coupled with increasing healthcare awareness, further support the market's expansion in North America.

Key players in the market

Some of the key players profiled in the Biophotonics Market include Thermo Fisher Scientific Inc., Carl Zeiss AG, Horiba Ltd., Olympus Corporation, Abcam Plc, Biolitec AG, Agilent Technologies Inc., Sartorius AG, Lumenis Ltd., PerkinElmer Inc. and LightLab Imaging, Inc.

Key Developments:

In November 2024, Carl Zeiss Meditec AG entered a strategic partnership with the Singapore Eye Research Institute (SERI). This collaboration focuses on improving surgical outcomes in refractive and cataract surgeries, with a funding commitment under Singapore's Research, Innovation and Enterprise.

In January 2024, Thermo Fisher announced a strategic collaboration with Galapagos NV for decentralized CAR-T manufacturing in the San Francisco area. This agreement includes providing GMP manufacturing and logistics services for Galapagos' CAR-T clinical program, marking a significant step in expanding their decentralized manufacturing strategy.

In July 2023, Carl Zeiss entered a long-term strategic partnership with the European Molecular Biology Laboratory (EMBL). This collaboration is focused on advancing research in molecular biology through innovative imaging technologies.

Technologies Covered:

In-vivo
In-vitro

Applications Covered:

See-through Imaging
Inside Imaging
Spectro Molecular
Surface Imaging
Microscopy
Light Therapy
Analytical Sensing
Biosensors
Other Applications

End Users Covered:

Medical Diagnostics
Medical Therapeutic
Tests & Components
Nonmedical Application
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Biophotonics Market, By Technology

5.1 Introduction
5.2 In-vivo
5.3 In-vitro

6 Global Biophotonics Market, By Application

6.1 Introduction
6.2 See-through Imaging
6.3 Inside Imaging
6.4 Spectro Molecular
6.5 Surface Imaging
6.6 Microscopy
6.6 Light Therapy
6.8 Analytical Sensing
6.9 Biosensors
6.10 Other Applications

7 Global Biophotonics Market, By End User

7.1 Introduction
7.2 Medical Diagnostics
7.3 Medical Therapeutic
7.4 Tests & Components
7.5 Nonmedical Application
7.6 Other End Users

8 Global Biophotonics Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 Thermo Fisher Scientific Inc.
10.2 Carl Zeiss AG
10.3 Horiba Ltd.
10.4 Olympus Corporation
10.5 Abcam Plc
10.6 Biolitec AG
10.7 Agilent Technologies Inc.
10.8 Sartorius AG
10.9 Lumenis Ltd.
10.10 PerkinElmer Inc.
10.11 LightLab Imaging, Inc.
10.12 Medtronic Plc
10.13 Photonis Technologies
10.14 Nikon Corporation
10.15 Beckman Coulter, Inc.

バイオフォトニクス市場の2030年までの予測：技術別、用途別、エンドユーザー別、地域別の世界分析

Biophotonics Market Forecasts to 2030 - Global Analysis By Technology (In-vivo and In-vitro), Application, End User and By Geography

最大シェアの地域

CAGRが最も高い地域：

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界のバイオフォトニクス市場：技術別

第6章 世界のバイオフォトニクス市場：用途別

第7章 世界のバイオフォトニクス市場：エンドユーザー別

第8章 世界のバイオフォトニクス市場：地域別

第9章 主な発展

第10章 企業プロファイリング